Skip to Main Content
Table 2—

Assessment of type of pain and other clinical data in relation to neuropathy

Degree of neuropathy assessed by the TCSSn (%)n (%) with PDPN or mixed painA1C (%) (means ± SD)Duration of diabetes (years) (means ± SD)
No neuropathy (0–5) 107 (39.8) 8 (7.4) 6.89 ± 1.3 6.09 ± 5.6 
Mild neuropathy (6–8) 98 (36.4) 20 (20.1) 7.26 ± 1.3 8.79 ± 6.5 
Moderate neuropathy (9–11) 37 (13.8) 24 (64.9) 7.49 ± 1.3 9.08 ± 8.5 
Severe neuropathy (12+) 28 (10.0) 19 (67.9) 8.13 ± 1.9 11.60 ± 8.4 
Total 269 (100) 71 (26.4) 7.26 ± 1.43 8.03 ± 6.9 
Degree of neuropathy assessed by the TCSSn (%)n (%) with PDPN or mixed painA1C (%) (means ± SD)Duration of diabetes (years) (means ± SD)
No neuropathy (0–5) 107 (39.8) 8 (7.4) 6.89 ± 1.3 6.09 ± 5.6 
Mild neuropathy (6–8) 98 (36.4) 20 (20.1) 7.26 ± 1.3 8.79 ± 6.5 
Moderate neuropathy (9–11) 37 (13.8) 24 (64.9) 7.49 ± 1.3 9.08 ± 8.5 
Severe neuropathy (12+) 28 (10.0) 19 (67.9) 8.13 ± 1.9 11.60 ± 8.4 
Total 269 (100) 71 (26.4) 7.26 ± 1.43 8.03 ± 6.9 
Close Modal

or Create an Account

Close Modal
Close Modal